3.22
3.22 (0%)
As of May 29, 2025
Galecto, Inc. [GLTO]
Source:
Company Overview
Galecto, Inc. is a clinical-stage biotechnology company developing novel small molecule therapeutics that are designed to target the biological processes that lie at the heart of cancer and liver diseases.
| Country | United States |
| Headquarters | boston, massachusetts |
| Phone Number | 45-70-70-52-10 |
| Industry | manufacturing |
| CEO | Hans T. Schambye |
| Website | clinicaltrials.gov |